The use of CRISPR/Cas9 gene editing technology to generate knockout cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knockout cell lines and cell lysates are widely recognized as the best negative controls, demonstrating the specificity of antibodies to target targets and ensuring reproducibility quickly and confidently.